Search

everythinglearnresearchcommunity

for

Search:↓

Hair hormone levels can indicate obesity-related changes and are useful for research and clinical practice.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Salivary testosterone is a better measure for hirsutism than serum testosterone.

AHR ligands could treat inflammatory skin diseases.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Sweating can potentially be controlled through olfactory receptors, with β-ionone playing a key role, and responses may vary between genders.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Certain herbal compounds might help prevent hair loss in menopausal women by activating Vitamin D receptors.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

PCOS has three subtypes, with 11-oxygenated androgens increasing metabolic risk.

Puberty is driven by hormonal changes, mainly influenced by genetics, nutrition, and body fat.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

Glucocorticoid and mineralocorticoid therapy effectively manage Congenital Adrenal Hyperplasia symptoms but have limitations.

Both hormonal and non-hormonal therapies improve hair growth in women, but non-hormonal methods may be more effective with fewer side effects.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Lower baseline prolactin levels may lead to better insulin resistance improvement with metformin in PCOS patients.

Surgery on a 68-year-old woman with an ovarian tumor led to reduced hirsutism and normal testosterone levels.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Excessive male hormones in women cause symptoms like unwanted hair growth, and treatment requires careful medical evaluation.